Dr. Ashby is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2910 N 3rd Ave
# 470
Phoenix, AZ 85013Phone+1 602-406-6262Fax+1 602-406-6261
Education & Training
- Barrow Neurological Institute at St Joseph's Hospital and Medical CenterFellowship, Neuro-Oncology, 1997 - 1999
- Barrow Neurological Institute at St Joseph's Hospital and Medical CenterResidency, Neurology, 1994 - 1997
- Northwestern University The Feinberg School of MedicineClass of 1993
Certifications & Licensure
- AZ State Medical License 1997 - 2026
- TX State Medical License 2017 - 2024
- NM State Medical License 2003 - 2011
- HI State Medical License 1999 - 2004
- IL State Medical License 1993 - 1996
- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 4 citationsNRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastoma.Tracy T Batchelor, Minhee Won, Arnab Chakravarti, Costas G Hadjipanayis, Wenyin Shi
Neuro-Oncology Advances. 2023-10-11 - 10 citationsLow-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539.C Leland Rogers, Stephanie L Pugh, Michael A Vogelbaum, Arie Perry, Lynn S Ashby
Neuro-Oncology. 2023-01-05 - 22 citationsJoint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors.Andrew B Lassman, Khê Hoang-Xuan, Mei-Yin C Polley, Alba A Brandes, J Gregory Cairncross
Journal of Clinical Oncology. 2022-08-10
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: